about
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesMEF2 transcription factors: developmental regulators and emerging cancer genesMutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomasNext-generation prognostic assessment for diffuse large B-cell lymphomaThe epigenetic basis of diffuse large B-cell lymphomaIdelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular LymphomaSWI/SNF chromatin remodeling complexes and cancerNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewA diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.The role of aberrant proteolysis in lymphomagenesisInterferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCORTargeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell LymphomaAge-related clonal hematopoiesis associated with adverse outcomesNature and importance of follicular lymphoma precursors.The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cellsDiscovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Socioeconomic disparities in lymphomaDistinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCLMutational analysis of primary central nervous system lymphoma.Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.Identification and analysis of driver missense mutations using rotation forest with feature selection.Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithmsUtilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.TET proteins and the control of cytosine demethylation in cancer.The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patientsDeregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesisProtein domain-level landscape of cancer-type-specific somatic mutations.
P2860
Q50348210-43B65107-C3A9-46F8-B85D-E09FF292A059Q54833249-EB45FC96-2BE8-4DBD-BCE5-C3EF55AD2B17Q54896490-E9F3030C-BAC0-43FD-9234-C462EE153559Q54899500-B36350D2-4664-484D-B1D8-1A3FC597E69EQ54931759-5F25EDE2-2EFA-45ED-B947-E6BC052C19CCQ54931760-6EBBBB91-137A-42BD-B445-54FF9C895B54Q54931771-2896151A-B8F3-4F3B-A7C7-1227F21BD5F8Q54931773-397F7D8F-EA2A-43F7-9655-717844915F24Q54931777-849393A0-7E1C-4DB9-86ED-4C0515EA23B5Q54931778-CD3F10D5-61EB-4AEF-9F96-B90C8D933149Q54947249-2BF639FE-EB85-4CF5-B38A-9D47E28D81E9Q54949416-CD73E8C6-D4ED-4F85-92CE-A5C0F930F8BEQ54950574-91111D46-416D-4A75-84A4-622F22A1902BQ54952223-7D416EF2-AE72-42BE-9C71-EAFA1F61793FQ54954741-E6F9F45E-7C9A-45BF-9AFC-ED832FAFBF38Q54970717-DB26B2D5-AEB8-48B8-88D1-BE8DB5BC3A9AQ54970722-4875D47A-7AA8-4A5C-B1D5-15CF3866E5D5Q54972694-CFD648E5-A1A6-4A9F-848A-CAD1AD5A4458Q54972777-E6B071E8-9F4F-49BD-A3B7-DB73AC1D3CB7Q54973560-2B4D0752-EFF4-4A52-AE13-1228F00E8513Q54994492-27A79604-0865-4F68-B617-0B9A239D447C
P1343
Q26744080-673F8E86-B6F7-4A4A-AA54-1F5A5FAEBF8DQ26778515-82310121-4977-42AB-BB54-6C4D903342B3Q26782506-4D086398-EE0A-4474-9851-92D7555553E8Q26796428-B4846235-499D-41B4-BCA4-7E22867D7A49Q26852288-0466D65D-E757-4C5F-A609-E3A386E0A106Q26865645-2BC1828C-6055-423A-AB98-9F181358A00EQ26998657-DFDD1A05-52D6-49F1-99E7-1E74D781A7F5Q27304386-8CE8C6BE-D8F6-4A66-A8AB-7EEDC29A20BDQ27852958-BC1F5603-1ABE-4BF3-95AE-62CBBFF76E3FQ28084404-95CAA9AD-ADA1-4327-9759-A263BD300315Q28115493-16E458EC-55E3-498A-B105-8B36B1232BC8Q28115962-64FBAE49-4BE1-4E75-989D-8584A826673AQ28386602-DBFFC56A-DB73-44B9-A2D1-F025C8FFAC43Q33558757-0FF04246-93AB-4563-B79A-EEEA75EF4680Q33585273-78689BF7-2B57-44F5-86EF-166F03459EBBQ33601156-5852383A-9982-44C6-82CC-C63EB98696EFQ33622342-4D2DA7A3-580E-4FC1-BCF1-90CF01156CDFQ33632104-C50FA7F2-15C4-409E-AEA8-CD14BA8D467CQ33687549-318C1DEE-A6C3-48D2-A557-19FB1E70F963Q33718800-35E5AA36-2E06-4530-9ED5-37A4C51CB57EQ33851726-B8E6ABD3-8BBE-4EEC-A14E-8CE383706B7FQ34100855-36DD3F94-5E87-4965-BBAE-FE34B0EB54CFQ34104139-FAEB9FCB-8E6D-4F84-97FD-81F715F5A309Q34155068-0133899B-D995-40E9-AA9B-9A7AE76184F8Q34177518-A3516196-C358-47AE-971F-8AC51391CD0DQ34302170-95E20CAA-CA69-4639-967B-ED06F0D8D84CQ34353717-E17D6F24-50C7-44CF-805B-593DFF9741C2Q34366539-6489BEA2-2529-451A-B11A-4A1764B8C5D4Q34481343-D4B202F9-F672-4A33-BE0A-01445712F4B3Q34494007-88B5BDB7-4394-4777-80E9-B0604E52FE52Q34617849-B3DAA8DB-334B-44AA-BF5E-DCA2893833A6Q34646755-20E8160E-9C97-4247-B2B9-137B7E667E32Q34695303-BB445649-6C12-4B1C-BB69-F2C553439EC2Q34714068-BBA04AC1-1861-4492-9673-58FDD113F56FQ34775356-184A27BB-2289-4664-B94E-019C27882ED4Q34860750-DDC836FD-AEF8-48E9-B719-D155A1684EE6Q35021377-59B016B1-753A-455D-B1B7-65A7C2EFB444Q35078037-71F427EF-6300-41F7-9CA1-7B90CA52C506Q35079601-55DA2467-7E52-4D80-A47A-AE74553F2EC4Q35203134-37408BAF-AFF9-49AD-94CF-A7FFD298D5B7
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genetic heterogeneity of diffuse large B-cell lymphoma
@ast
Genetic heterogeneity of diffuse large B-cell lymphoma
@en
type
label
Genetic heterogeneity of diffuse large B-cell lymphoma
@ast
Genetic heterogeneity of diffuse large B-cell lymphoma
@en
prefLabel
Genetic heterogeneity of diffuse large B-cell lymphoma
@ast
Genetic heterogeneity of diffuse large B-cell lymphoma
@en
P2093
P2860
P4510
P50
P356
P1476
Genetic heterogeneity of diffuse large B-cell lymphoma
@en
P2093
Amy Chadburn
Amy J Johnson
Anand S Lagoo
Anjishnu Banerjee
Cassandra L Love
Cherie Dunphy
Christopher Flowers
David A Rizzieri
David Dunson
P2860
P304
P356
10.1073/PNAS.1205299110
P407
P577
2013-01-04T00:00:00Z